Title: FDA Recommends Spacing Out Vaccinations for Respiratory Viruses This Fall and Winter
In light of the upcoming fall and winter seasons, the Food and Drug Administration (FDA) is advising individuals to space out their vaccinations for respiratory viruses. This recommendation aims to minimize the chances of side effects and interactions due to multiple vaccines being administered simultaneously.
Dr. Peter Marks, the director of the FDA’s Center for Biologics Evaluation and Research, is leading by example. He intends to receive the COVID-19 vaccine first and then get his flu shot in early October. Dr. Marks acknowledges that receiving multiple different vaccines at the same time can potentially result in more side effects, such as fatigue or a slight fever.
To mitigate the risks, Dr. Marks suggests spacing out the vaccinations by two weeks. This approach can minimize the possibility of interactions and avoid confusing side effects. While this may require multiple visits to the pharmacy or doctor’s office, it provides added safety and peace of mind.
Dr. Marks plans to prioritize the updated COVID-19 vaccine as it appears to be effective against the currently circulating strains, including the XBB.1.5 and BA.2.86 variants. He also predicts a moderate wave of COVID-19 cases during the colder months and suggests that additional doses might be offered later in the fall and winter.
In addition to COVID-19 and flu shots, Americans now have new options to protect against respiratory syncytial virus (RSV) this year. Pfizer and GSK have developed vaccines specifically for older adults. RSV infections have started to accelerate in certain regions, particularly in the Southeast.
CDC advisors will be voting on updated recommendations for administering Pfizer’s new RSV vaccine during pregnancy to protect newborns. This significant development could play a crucial role in safeguarding vulnerable infants from RSV.
Moreover, Sanofi and AstraZeneca have joined forces to create a new antibody injection for babies born prematurely, offering additional protection ahead of the upcoming RSV season.
The fall and winter seasons bring with them an increased risk of respiratory viruses. By spacing out vaccinations and taking advantage of newly available options, individuals can proactively protect themselves against COVID-19, flu, and RSV. Following the FDA’s recommendations, individuals can ensure their health and well-being throughout the colder months.
“Infuriatingly humble tv expert. Friendly student. Travel fanatic. Bacon fan. Unable to type with boxing gloves on.”